Tenke, P., Köves, B.
, Nagy, K., Hultgren, S. J., Mendling, W., Wullt, B., Grabe, M., Wagenlehner, F. M. E., Cek, M., Pickard, R., Botto, H., Naber, K. G.
& Bjerklund Johansen, T. E. (2011).
Update on biofilm infections in the urinary tract.
World Journal of Urology.
https://doi.org/10.1007/s00345-011-0689-9
Kote-Jarai, Z., Olama, A. A. A., Giles, G. G., Severi, G., Schleutker, J., Weischer, M., Campa, D., Riboli, E., Key, T., Gronberg, H., Hunter, D. J., Kraft, P., Thun, M. J., Ingles, S., Chanock, S., Albanes, D., Hayes, R. B., Neal, D. E., Hamdy, F. C. ... The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology (2011).
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
Nature Genetics,
43(8), 785-791.
https://doi.org/10.1038/ng.882
Wagenlehner, F. M. E., Grabe, M., Naber, K. G.
, Johansen, T. E. B., Naber, C. K. & Weidner, W. (2011).
Antibiotikaprophylaxe in der Urologie.
Urologe. Section A,
50(11), 1469-78; quiz 1479-80.
https://doi.org/10.1007/s00120-011-2661-0
Jensen, B. T., Dielenseger, P., Drudge-Coates, L., Flynn, K., Hieronymi, S., van Muilekom, E., Pieters, R. & Bjerregaard Voss, L. (2011).
Taking the lead - best practice recommendations for intravenenous bisphosphonate use in urological cancers.
European Journal of Oncology Nursing.